MAPT and Alzheimer disease: The vascular abnormalities and damages in our NHP model of AD (Fig. 8) may result from perivascular tau accumulation, tau toxicity and neuroinflammation, which may impact vascular architecture, cerebral blood flow and BBB integrity.